Related Experiment Videos
In vitro additive effect of polymxin B and rifampin against Serratia marcesen
Antimicrobial Agents and Chemotherapy
|June 1, 1975
Abstract:
The combination of polymyxin B and rifampin resulted in an additive effect against all 12 clinical isolates of Serratia marcescens examined, including multiple-drug-resistant isolates.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Examination of polyclonal rabbit immune sera against serovars of Acinetobacter baumannii and genospecies 3 for cross-reactions with reference strains of other named/unnamed genospecies of Acinetobacter.
Zentralblatt fur Bakteriologie : international journal of medical microbiology·2000
Serotyping of clinical isolates of Acinetobacter baumannii and genospecies 13 capable of growth at 44 degrees C: detection of four new serovars.
Zentralblatt fur Bakteriologie : international journal of medical microbiology·1998
Screening of a chemogenetic library unveils dual-stage antiplasmodials with low cytotoxicity.
Antimicrobial agents and chemotherapy·2026
OT-CATH, a conserved antimicrobial peptide in Otariidae species, exhibits potent activity against gram-negative bacteria.
Antimicrobial agents and chemotherapy·2026
Pulmonary pharmacokinetics and lesion penetration of antimicrobials in patients with nontuberculous mycobacterial disease.
Antimicrobial agents and chemotherapy·2026
G-quadruplex-binding ligand RHPS4 reduces Plasmodium falciparum mitochondrial DNA level providing a novel antimalarial strategy.
Antimicrobial agents and chemotherapy·2026
Clinical Evaluation of a Stool-Based Molecular Point-of-Care Test Kit for Noninvasive Detection of Helicobacter pylori Infection and Clarithromycin Resistance.
Canadian journal of gastroenterology & hepatology·2026
Host factors, not Mycobacterium tuberculosis lineage, predict unfavorable outcomes in drug-susceptible pulmonary tuberculosis: evidence from RePORT-Brazil.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Newly Identified FDA-Approved MTAs: Opportunities for Antimicrobial Repurposing?
Biochemistry. Biokhimiia·2026
Mechanisms by Which the Cervicovaginal Microbiota Mediates Endometrial Repair Following Uterine Injury: A Review of Recent Advances.
International journal of general medicine·2026